Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +48.17%
#3 Velvet Velvet +37.34%
#4 Black Phoenix Black Phoenix +34.06%
#5 Akedo Akedo +29.10%
#6 Cross Cross +27.01%
#7 Cap Cap +18.79%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.46%
#9 QANplatform QANplatform +14.35%
#10 Bitway Bitway +13.02%
Coin of the day
Glidr Glidr
設定
言語
日本
通貨
USD
テーマ
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.

ZVSA
株式のランク #38792
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical... ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
株価
$0.099
時価総額
$801.50K
変化（1日）
0.00%
変化（1年）
-34.44%
国
US
取引 ZyVersa Therapeutics, Inc. (ZVSA)

カテゴリー

Healthcare
ZyVersa Therapeutics, Inc.（ZVSA）の株価履歴
終値の最高値: $0.11 （2026-08-01）

終値の最安値: $3.45K （2022-02-01）
ZyVersa Therapeutics, Inc. の株価履歴（2022 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) 21.33%
2025 -87.48%
2024 -90.24%
2023 -99.49%
2022 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $508.06 30.17%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $849.76 30.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE